EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries

Wendy Wang iD, Lin Yee Chen, Rob F Walker, Alvaro Alonso, Faye L Norby, Kamakshi Lakshminarayan, Pamela L Lutsey

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Wendy Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Atrial Appendage, Stroke, Atrial Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Among patients with atrial fibrillation (AF), a nonpharmacologic option (e.g., percutaneous left atrial appendage occlusion [LAAO]) is needed for patients with oral anticoagulant (OAC) contraindications. Among beneficiaries in the Medicare fee‐for‐service coverage 20% sample databases (2015–18) who had AF and an elevated CHA 2 DS 2 ‐VASc score, we assessed the association between percutaneous LAAO versus OAC use and risk of stroke, hospitalized bleeding, and death.

Methods

Patients undergoing percutaneous LAAO were matched to up to five OAC users by sex, age, date of enrollment, index date, CHA 2 DS 2 ‐VASc score, and HAS‐BLED score. Overall, 17 156 patients with AF (2905 with percutaneous LAAO) were matched (average ± SD 78 ± 6 years, 44% female). Cox proportional hazards model were used.

Results

Median follow‐up was 10.3 months. After multivariable adjustments, no significant difference for risk of stroke or death was noted when patients with percutaneous LAAO were compared with OAC users (HRs [95% CIs]: 1.14 [0.86–1.52], 0.98 [0.86–1.10]). There was a 2.94‐fold (95% CI: 2.50–3.45) increased risk for hospitalized bleeding for percutaneous LAAO compared with OAC use. Among patients 65 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageStrokeAtrial FibrillationHumansFemaleAgedUnited StatesMaleTreatment OutcomeMedicareHemorrhageAnticoagulants

Stichwörter der Autor:innen

atrial fibrillationhospitalized bleedingpercutaneous LAAOstroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Lillehei Heart Institute and Department of Medicine (Cardiovascular Division), University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Wendy Wang

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Wang, W., Chen, L. Y., Walker, R. F., Alonso, A., Norby, F. L., Lakshminarayan, K., & Lutsey, P. L. (2024). Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5786

Vancouver

Wang W, Chen LY, Walker RF, Alonso A, Norby FL, Lakshminarayan K, et al. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5786

BibTeX
@article{Wang2024,
  author = {Wang, Wendy and Chen, Lin Yee and Walker, Rob F and Alonso, Alvaro and Norby, Faye L and Lakshminarayan, Kamakshi and Lutsey, Pamela L},
  title = {Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5786}
}
Kostenlos starten →